Vasopressin test in central nervous system-pituitary disorders.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000172:Acromegaly / Q000503:physiopathology*; D000238:Adenoma, Chromophobe / Q000503:physiopathology*; D000311:Adrenal Glands / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D001927:Brain Diseases / Q000503:physiopathology*; D002493:Central Nervous System Diseases / Q000175:diagnosis; D002986:Clinical Trials as Topic; D006259:Craniocerebral Trauma / Q000503:physiopathology*; D003919:Diabetes Insipidus / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007427:Intracranial Pressure; D008297:Male; D008797:Metyrapone; D010900:Pituitary Diseases / Q000175:diagnosis; D010901:Pituitary Function Tests; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D011559:Pseudotumor Cerebri / Q000503:physiopathology; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone